In December 2011, Baltvesta performed a buy out from its partners and now it remains the 98,5% stakeholder. |
| In May 2011, Shareholders of Sanitas signed a share sale and purchase agreement for the sale of their entire shareholding to Valeant Pharmaceuticals International, Inc. (“Valeant”). |
| Currently Baltvesta is selling investment projects in Tbilisi, Georgia |
|